Sofinnova Investments, Inc. Mirum Pharmaceuticals, Inc. Transaction History

Sofinnova Investments, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 14, 2024	BUY	$24.92 - $30.02 $75,059 - $90,420	3,012 New	3,012 $75,000
Q1 2024 May 15, 2024	SELL	$24.92 - $30.02 $8.71 Million - $10.5 Million	-349,385 Reduced 99.15%	3,012 $75,000
Q4 2023 Aug 15, 2024	BUY	$27.14 - $34.93 $9.56 Million - $12.3 Million	352,397 New	352,397 $10.4 Million
Q4 2023 Feb 12, 2024	BUY	$27.14 - $34.93 $9.32 Million - $12 Million	343,308 Added 3777.18%	352,397 $10.4 Million
Q2 2023 Aug 14, 2023	BUY	$23.51 - $30.09 $213,682 - $273,488	9,089 New	9,089 $235,000
Q3 2021 Nov 15, 2021	SELL	$13.95 - $20.18 $3.62 Million - $5.24 Million	-259,465 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$15.84 - $20.6 $3.44 Million - $4.47 Million	-216,936 Reduced 45.54%	259,465 $4.49 Million
Q1 2021 May 14, 2021	BUY	$16.29 - $21.92 $349,045 - $469,679	21,427 Added 4.71%	476,401 $9.44 Million
Q4 2020 Feb 16, 2021	BUY	$15.75 - $25.45 $2.11 Million - $3.4 Million	133,722 Added 41.63%	454,974 $7.94 Million
Q3 2020 Nov 13, 2020	SELL	$18.4 - $26.59 $4.06 Million - $5.86 Million	-220,449 Reduced 40.7%	321,252 $6.19 Million
Q2 2020 Aug 13, 2020	BUY	$11.51 - $20.97 $1.42 Million - $2.58 Million	123,112 Added 29.41%	541,701 $10.5 Million
Q1 2020 May 13, 2020	BUY	$9.38 - $23.79 $3.93 Million - $9.96 Million	418,589 New	418,589 $5.86 Million

190

54M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.64B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.